Press Play with Madeleine Brand
COVID-19 vaccine trials: Some promising results, still many unknowns
KCRW looks at the Oxford-AstraZeneca coronavirus vaccine trial, the importance of both safety and effectiveness, and the complications of rolling out a vaccine on a global scale. “The other major unknown is how long vaccine immunity will…
KCRW looks at the Oxford-AstraZeneca coronavirus vaccine trial, the importance of both safety and effectiveness, and the complications of rolling out a vaccine on a global scale.
“The other major unknown is how long vaccine immunity will last. … Coronavirus immunity may be much shorter than anything to do with, say, measles. So a vaccine response may diminish in intensity after several months, and may need additional booster shots. We don't know yet,” says John P. Moore, Professor of Microbiology and Immunology at Weill Cornell Medical College.
In this episode
4 storiesExtra unemployment money will run out soon for millions of Americans. Will Congress extend it?
Joe Biden today is unveiling a 10-year, $775 billion plan to provide daycare, elder care, and care for the disabled. He’s also laying out a proposal for emergency funding to states to help child care centers during the pandemic.
Read the story10 minCOVID-19 vaccine: How long immunity will last and other unknowns
KCRW looks at the Oxford-AstraZeneca coronavirus vaccine trial, the importance of both safety and effectiveness, and the complications of rolling out a vaccine on a global scale.
Read the story10 min‘Deacon King Kong’ is set in NY housing project, shows big picture of Black life
In a Brooklyn housing project in 1969, an old church deacon known as Sportcoat walks into the courtyard in the middle of the day and shoots the neighborhood drug dealer. There are lots of witnesses.
Read the story16 minNetflix’s rise and nearly cult-like corporate culture
The birth of Netflix wasn’t just the death knell for video stores like Blockbuster. It reshaped how the world watches TV.
Read the story14 min